Retrospective Study of Seno Medical’s Imagio® Breast Imaging System Published in American Journal of Roentgenology Shows System May Help Reduce Biopsies of Benign Breast Masses Compared to Ultrasound Alone

Study found OA/US fused imaging significantly improved specificity at fixed sensitivity compared to conventional ultrasound  [SAN ANTONIO, TX – January 5, 2023] A retrospective study of Seno Medical‘s Imagio® Breast Imaging System published in the American Journal of Roentgenology found that the company’s opto-acoustic/ultrasound (OA/US) technology significantly improves specificity at fixed sensitivity compared to conventional ultrasound. The study, Optoacoustic […]

Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Conf

[SAN ANTONIO, TX – December 1, 2021] A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s Imagio® opto-acoustic ultrasound (OA/US) breast imaging provides significantly better specificity than ultrasound alone. The poster, “Performance of Optoacoustic Ultrasound with an Artificial Intelligence-based Decision Support Tool vs Ultrasound Alone to Classify […]

Seno Medical’s Market-Ready Imagio® OA/US Breast Imaging System Launches at RSNA 2022, Booth 6120

The category defining Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology. [SAN ANTONIO, TX – November 27, 2022] Seno Medical, makers of the Imagio® Breast Imaging System – a revolutionary new modality in breast imaging – will officially launch the commercially available system at […]